Form 8-K - Current report:
SEC Accession No. 0000320017-17-000043
Filing Date
2017-05-17
Accepted
2017-05-16 18:12:35
Documents
6
Period of Report
2017-05-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 05.16.17 BR LEASE a8-k051517.htm 8-K 24030
2 EXHIBIT 10.1 NEW LEASE exhibit101110allenrdleasea.htm EX-10.1 606734
3 EXHIBIT 10.2 TERMINATION LEASE AGREEMENT exhibit102terminationof106.htm EX-10.2 41295
4 EXHIBIT IMAGE a110allenrda02.jpg GRAPHIC 109015
5 EXHIBIT IMAGE exhibite110allenroada08.jpg GRAPHIC 117073
6 EXHIBIT IMAGE exhibite2110allenrd.jpg GRAPHIC 95906
  Complete submission text file 0000320017-17-000043.txt   1117479
Mailing Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920
Business Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920 908-842-0100
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33650 | Film No.: 17849842
SIC: 8090 Services-Misc Health & Allied Services, NEC